SynthesisFrontiers in pharmacology2023

Comparison of the efficacy and safety of first-line treatments for of advanced EGFR mutation-positive non-small-cell lung cancer in Asian populations: a systematic review and network meta-analysis.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.